|
Hello Subscribers,
New breakout alert on Cannabis Science, Inc. (CBIS)
Last time we saw CBIS dip down to these levels it had a nice bounce up to the .04c range. Keep a close eye on CBIS and do your research before tomorrow.
Quote: www.finance.yahoo.com/q?s=CBIS
Website: www.cannabisscience.com
Major news was released last week. I am shocked we saw the market come off.
CBIS is one active company that continues to release big news and trade large volume. One thing about CBIS is that we could see big swings in very little time.
News Release:
Cannabis Science to Begin Its Drug Development Program With IGXBio and Its GenePro(R), DNA-Based Immunotherapeudic, FDA IND # Approved
CBIS also released this as a bonus to all shareholders:
Cannabis Science Positions Itself to Issue Dividend Payouts to Its Shareholders
CBIS works with leading experts in drug development, medicinal characterization and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment of illnesses caused by infections as well as for age-related illness. The Company’s initial focus is on skin cancers and neurological conditions.
Now while there may be quite a few MJ startups playing games out there, CBIS seems to be the real deal. Just take a look at this WSJ article “Pot Industry Puts on a Tie” released earlier this month, spotlighting the Chief Financial Officer at CBIS, Robert Kane.
Now that is about as big of a deal as it gets.
What we may be looking at is the next Boon market. Startups in the MJ sector could soon be touting Bln Dlr IPO’s and numbers like this show why; MarijuanaIndex(dot)org lists over 40 publicly traded companies in the industry, with a combined market capitalization of nearly 4Bln Dlrs.
The MJ market is quickly becoming Big Business, there is a race happening right now to find out who ends up on top and with the way it is looking CBIS certainly appears to hold a lot of of the cards right now.
To get an idea on just how enormous this market is and the potential it has to transform these small market companies just look at these figures:
• According to government surveys, some 25M Americans have smoked MJ in the past year, and more than 14M Americans do so on a regular basis.
• Studies have shown the MJ market could be valued at a staggering 120Bln Dlrs.
• The public is trending towards legalization. In a Pew Research Center poll, a majority of Americans (52%) favored legalization, the first time that threshold has been reached since polling began on that issue back in 1969.
• With 2.4M Med-MJ patients in the U.S. this market is already absolutely enormous and with the direction the Country is moving things are only getting larger.
• A budget proposal from Colorado Gov. estimates MJ sales would reach approximately 610M next fiscal year.
The market for Med MJ has exploded in recent years with many states reporting massive growth. From a recent survey, sales from MJ stores in the Los Angeles area alone are estimated at 3Bln Dlrs per year, and maybe even more.
Considering the size of the L.A. market alone, the national market could reach as high as 100 Bln Dlrs.
Now in case you haven’t heard the news yet… New York has become the latest state to permit the use of Med-MJ. In doing so Gov. Andrew Cuomo has opened one of the largest marketplaces to companies focused on medical grade MJ treatments.
In addition to several recent announcements of clinical trials and other research surrounding their proprietary formulations of cannabinoid treatments, the Company has also made waves with its financial postings.
In its fiscal year ending March 31st, CBIS has tripled its Total Assets and lowered its net losses by nearly 2/3rds, all the while raising sufficient capital to use to invest in its pre-clinical drug development.
The Company has also recently signed a distribution agreement with MDS, which is owned by Medbox Inc., that will garner the company half the gross profits on MDS equipment sold in markets across nearly every continent on earth. In addition, a unique partnership with Dutch cannabis company Mediwiet will enable CBIS to conduct one of the world’s largest observational studies on medicinal cannabis-based medicine.
With landmark legislation opening up new, untapped markets seemingly every month, CBIS couldn’t ask for much more…
… so get started on researching this exciting young MedMJ company right away.
Remember, we always encourage you to do further research. Never take our word for it, read our disclaimer to see why, and of course always consult a professional.
Just because a situation looks great things can still go wrong and often do. Be smart and protect yourself.
Enjoy your evening,
Never forget that I am not a broker, analyst or financial advisor in any capacity. These are my opinions and I could always be wrong.
Best Regards,
staff@SmallCapAllstars.com
|
